NuVasive Inc (NUVA)

75.30
0.02 0.03
NASDAQ : Health Care
Prev Close 75.32
Open 75.34
Day Low/High 74.93 / 75.50
52 Wk Low/High 36.81 / 62.95
Volume 252.68K
Avg Volume 527.30K
Exchange NASDAQ
Shares Outstanding 50.60M
Market Cap 3.81B
EPS 0.70
P/E Ratio 109.12
Div & Yield N.A. (N.A)

Latest News

Masimo's Stock Is a Great Buy Right Now

Masimo's Stock Is a Great Buy Right Now

This patient-monitoring device-maker has plenty of room for growth.

NUVA: Insiders vs. Shorts

NUVA: Insiders vs. Shorts

The most recent short interest data was recently released for the 01/13/2017 settlement date, and Nuvasive Inc is one of the most shorted stocks of the Russell 3000, based on 6.67 "days to cover" versus the median component at 5.04. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Are People Finally Noticing?

Recognition of the market's inertia seems to be growing.

NXPI, AAPL, C: Jim Cramer's Views

NXPI, AAPL, C: Jim Cramer's Views

Cramer shares his views on takeover talks. NXP Semiconductor, Apple and Citigroup are among the stocks discussed.

Bearish Bets: A Couple Industrials, a Household Name and Other Stocks That Look Good Short

PNR, PCAR, NUVA, TUP and CREE all were recently downgraded by TheStreet's Quant Ratings.

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

Cramer: Demand Lifts Defense, Aerospace, Cyber-Security, Regional Bank Stocks

But several airline and retail stocks are proving highly volatile.

NuVasive (NUVA) Stock Tumbles on Q3 Revenue Miss, Outlook

NuVasive (NUVA) Stock Tumbles on Q3 Revenue Miss, Outlook

NuVasive (NUVA) reported light revenue for the 2016 third quarter late Tuesday.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: HNP, QTS, SRLP, TCBI, UA, ZIXI Downgrades: BGSF, BXP, CAT, CIT, NUVA, PCAR, PNR, VLO Initiations: JAX Read on to get TheStreet Quant Ratings' detailed report:

7 Unusual-Volume Stocks That Are About to Break Out

7 Unusual-Volume Stocks That Are About to Break Out

These stocks rising on unusual volume are within range of triggering big breakout trades.

Perrenial Target and Acquirer NuVasive Names New President and COO

Perrenial Target and Acquirer NuVasive Names New President and COO

The medical device company taps Jason Hannon, an 11-year company veteran, as its new president and COO, succeeding Patrick Miles, who was appointed vice chairman.

These 4 Medical Technology Stocks Really Stand Out

These 4 Medical Technology Stocks Really Stand Out

Medical technology companies are hot, says Rich Newitter, managing director at Leerink.

4 Standout Medical Technology Stocks

4 Standout Medical Technology Stocks

Medical technology companies are hot and not even climbing price-to-earnings multiples will slow down the likes of Hologic, Zimmer Biomet, Zeltiq and NuVasive.

Looking for Healthcare Stocks? Consider These Four

Looking for Healthcare Stocks? Consider These Four

These four small-cap stocks would be a healthy addition to your portfolio, says David Swank, portfolio manager for the Hood River Small-Cap Growth Fund.

Where Will a Healthy Zimmer Biomet Turn Next for Acquisitions?

Where Will a Healthy Zimmer Biomet Turn Next for Acquisitions?

Zimmer's return to growth is fueling acquisition thoughts by analysts. There are a number of possibilities.

Zimmer Biomet and NuVasive Could be a Spine-Tingling Combination

Zimmer Biomet and NuVasive Could be a Spine-Tingling Combination

Zimmer Biomet is on track to return to growth, which could signal more mergers and acquisitions within the industry.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AWRE, CRD.B, NUVA, SIRI, SNBC, TI, TI.A, TNC Downgrades: DD, HOT, TRNS, TROW, ZIXI Initiations: TRU, XTLY, YECO Read on to get TheStreet Quant Ratings' detailed report:

New Lifetime High Reached By NuVasive (NUVA)

New Lifetime High Reached By NuVasive (NUVA)

Trade-Ideas LLC identified NuVasive (NUVA) as a new lifetime high candidate

Analysts' Actions -- Darden, MetLife, Pandora, Yelp and More

Analysts' Actions -- Darden, MetLife, Pandora, Yelp and More

Here are Wednesday's top research calls, including an upgrade for Pandora, and downgrades for Darden Restaurants, MetLife and Yelp.

Bottom Fishers Rise to the Occasion

This group of nibblers triggered a modest reversal leading into the Fed’s late-afternoon minutes.

4 Medical Device Makers With Healthy-Looking Charts

4 Medical Device Makers With Healthy-Looking Charts

These medical device makers could be acquisition targets (and one buyer) following Zimmer Biomet's takeout of LDR Holding. Their charts are also buys, says technical chartist Bruce Kamich.

Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine

Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine

The $1 billion transaction could inspire other medical device companies and private equity firms to bend over backwards for spinal device assets.

Rival Offer for LDR Is Unlikely, but Never Say Never

Rival Offer for LDR Is Unlikely, but Never Say Never

The hefty premium Zimmer Biomet is paying in the $1 billion deal for the spine company suggests the target's management followed a competitive process.

Cramer Says Buy NuVasive on Heels of Zimmer's LDR Deal

Cramer Says Buy NuVasive on Heels of Zimmer's LDR Deal

The target's shares soar on heels of latest back treatment acquisition.

Jim Cramer: Zimmer-LDR Deal Is Great

Jim Cramer: Zimmer-LDR Deal Is Great

Zimmer Biomet's move to acquire LDR Holding is a smart one and it also bodes well for another medical device company NuVasive, said TheStreet's Jim Cramer.

NuVasive (NUVA) Hits New Lifetime High

NuVasive (NUVA) Hits New Lifetime High

Trade-Ideas LLC identified NuVasive (NUVA) as a new lifetime high candidate

Where Are the Numbers Coming From?: Jim Cramer’s Best Blogs

Where Are the Numbers Coming From?: Jim Cramer’s Best Blogs

Jim Cramer talks about how the jobs numbers baffle him and says not to give up on this market.